These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35389983)

  • 1. Adaptive and optimized COVID-19 vaccination strategies across geographical regions and age groups.
    Molla J; Ponce de León Chávez A; Hiraoka T; Ala-Nissila T; Kivelä M; Leskelä L
    PLoS Comput Biol; 2022 Apr; 18(4):e1009974. PubMed ID: 35389983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization.
    Miura F; Leung KY; Klinkenberg D; Ainslie KEC; Wallinga J
    PLoS Comput Biol; 2021 Dec; 17(12):e1009697. PubMed ID: 34898617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of vaccine prioritization strategies on mitigating COVID-19: an agent-based simulation study using an urban region in the United States.
    Tatapudi H; Das R; Das TK
    BMC Med Res Methodol; 2021 Dec; 21(1):272. PubMed ID: 34865617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the best time interval between doses in a two-dose vaccination regimen to reduce the number of deaths in an ongoing epidemic of SARS-CoV-2.
    Souto Ferreira L; Canton O; da Silva RLP; Poloni S; Sudbrack V; Borges ME; Franco C; Marquitti FMD; de Moraes JC; Veras MASM; Kraenkel RA; Coutinho RM
    PLoS Comput Biol; 2022 Mar; 18(3):e1009978. PubMed ID: 35333872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abrupt transition of the efficient vaccination strategy in a population with heterogeneous fatality rates.
    Jhun B; Choi H
    Chaos; 2022 Sep; 32(9):093140. PubMed ID: 36182386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing vaccination priorities for different ages and age-specific vaccination strategies of COVID-19 using an SEIR modelling approach.
    Yang C; Yang Y; Li Y
    PLoS One; 2021; 16(12):e0261236. PubMed ID: 34936650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity.
    Han S; Cai J; Yang J; Zhang J; Wu Q; Zheng W; Shi H; Ajelli M; Zhou XH; Yu H
    Nat Commun; 2021 Aug; 12(1):4673. PubMed ID: 34344871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 epidemic in New York City: development of an age group-specific mathematical model to predict the outcome of various vaccination strategies.
    Li M; Zu J; Zhang Y; Ma L; Shen M; Li Z; Ji F
    Virol J; 2022 Mar; 19(1):43. PubMed ID: 35292054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the transition of COVID-19 burden towards the young population while vaccines are rolled out in China.
    Cai J; Yang J; Deng X; Peng C; Chen X; Wu Q; Liu H; Zhang J; Zheng W; Zou J; Zhao Z; Ajelli M; Yu H
    Emerg Microbes Infect; 2022 Dec; 11(1):1205-1214. PubMed ID: 35380100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the impact of vaccination strategies on the spread of COVID-19, including a novel household-targeted vaccination strategy.
    Voigt A; Omholt S; Almaas E
    PLoS One; 2022; 17(2):e0263155. PubMed ID: 35108311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urban monitoring, evaluation and application of COVID-19 listed vaccine effectiveness: a health code blockchain study.
    Wang T; Li C; Li H; Li Z
    BMJ Open; 2022 Jul; 12(7):e057281. PubMed ID: 35831042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The balancing role of distribution speed against varying efficacy levels of COVID-19 vaccines under variants.
    Kim D; Keskinocak P; Pekgün P; Yildirim İ
    Sci Rep; 2022 May; 12(1):7493. PubMed ID: 35523832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal control-based vaccination and testing strategies for COVID-19.
    Olivares A; Staffetti E
    Comput Methods Programs Biomed; 2021 Nov; 211():106411. PubMed ID: 34600408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal control of the spatial allocation of COVID-19 vaccines: Italy as a case study.
    Lemaitre JC; Pasetto D; Zanon M; Bertuzzo E; Mari L; Miccoli S; Casagrandi R; Gatto M; Rinaldo A
    PLoS Comput Biol; 2022 Jul; 18(7):e1010237. PubMed ID: 35802755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.
    COVIDSurg Collaborative, GlobalSurg Collaborative
    Br J Surg; 2021 Sep; 108(9):1056-1063. PubMed ID: 33761533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects.
    Bicher M; Rippinger C; Schneckenreither G; Weibrecht N; Urach C; Zechmeister M; Brunmeir D; Huf W; Popper N
    Sci Rep; 2022 Feb; 12(1):2872. PubMed ID: 35190590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategic spatiotemporal vaccine distribution increases the survival rate in an infectious disease like Covid-19.
    Grauer J; Löwen H; Liebchen B
    Sci Rep; 2020 Dec; 10(1):21594. PubMed ID: 33299029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study.
    Diarra M; Kebir A; Talla C; Barry A; Faye J; Louati D; Opatowski L; Diop M; ; White LJ; Loucoubar C; Miled SB
    BMJ Glob Health; 2022 Feb; 7(2):. PubMed ID: 35193893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.